Category: Prostate Cancer

  • A Step Backward: The ACPM Recommendations on Prostate Cancer Screening

    Medscape article summarizing PSA recommendations: The most aggressive screening protocol is from the NCCN. NCCN guidelines start from the premise that the patient has made a decision to seek early prostate cancer detection. They recommend beginning screening at age 40. The baseline PSA level, race, and family history are then used to determine the subsequent…

  • Long-Term Functional and Oncological Outcomes of Patients Undergoing Sural Nerve Interposition Grafting during dvP

    From UroToday: Despite optimism regarding SNG, long-term functional outcomes have been disappointing, particularly for BL nerve interposition. UL-SNG functional outcomes do not appear to improve outcomes when compared with men with UL nerve preservation. With the greater risk of PSM and BCR in patients who are considered candidates for SNG, newer treatment modalities are needed…

  • Upgrading after radical prostatectomy

    UroToday – Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading – Abstract Preoperative prostate specific antigen greater than 5.0 ng/ml (p = 0.036), prostate weight 60 gm or less (p = 0.004) and more cancer volume at biopsy, defined by cancer involving greater than 5% of the biopsy tissue (p = 0.002), greater than…

  • Positive margins and their significance

    UroToday – Prognostic Significance of Location of Positive Margins in Radical Prostatectomy Specimens In the 201 men with a single positive SM, it was found in the apex in 75 men (37%), posterolateral in 70 men (35%), bladder neck in 20 men (10%), anterior in 25 men (12%), posterior in 11 men (5%), and in…

  • IMRT external beam radiation review

    UroToday – Current Status of Intensity-Modulated Radiation Therapy (IMRT) In the International Journal of Clinical Oncology, Dr. Hatano and colleagues from Chiba, Japan provide an excellent overview of intensity-modulated radiation therapy (IMRT). Problems with conventional, four field radiotherapy have been ineffective dose distribution and overdoses to organs at risk (OARs), such as the bladder and…

  • Screening for prostate cancer

    The controversy over screening for prostate cancer will continue. clipped from www.medscape.com Information is not adequate to recommend screening men for prostate cancer with digital rectal examination or measurement of prostate-specific antigen (PSA), according to a position statement by the American College of Preventive Medicine (ACPM) published in the February issue of the American Journal…

  • Effect on prostate size on prostatectomy recovery

    clipped from www.medwire-news.md “Prostate size has no effect on continence or biochemical recurrence at 1 year after laparoscopic radical prostatectomy, but affects intra-operative blood loss, potency and surgical margins,” Aron et al write in the BJU International. The study points out what most people are concluding in regards to positive margins. Smaller prostate tend to…

  • New genetic tests to be developed for prostate cancer

    Genetic test in three years to detect prostate cancer | Science | The Guardian: “A genetic test that identifies men most at risk of prostate cancer could be available within three years, scientists said yesterday. British doctors will use the test in screening programmes to spot the disease in its earliest stages, before it has…

  • Excellent book for prostate cancer patients

    clipped from www.prostatecancerfoundation.org Report to the Nation on Prostate Cancer: A Guide for Men and Their Families Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the life of the man diagnosed, but also the lives of his family members…